DelSiTech Awarded a Grant to Develop Controlled and Sustained Release Injectables for Prophylactic HIV Vaccine Aleksi Leino2023-03-15T11:34:26+02:00March 15th, 2023| Read More
DelSiTech Ltd Announces Appointment of Dr. Sari Häkkinen as Chief Development Officer Aleksi Leino2023-03-22T16:06:07+02:00March 1st, 2023| Read More
DelSiTech and Iveric Bio Enter Exclusive Agreement for Development of Sustained Release Zimura® Aleksi Leino2022-07-06T01:12:35+02:00July 6th, 2022| Read More
